Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 915-761-2 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The acute oral LD50 of Basic Red 046 Methylsulfate was determined to be 1635 mg/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 27 May, 1980 to 23 June, 1980
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Justification for type of information:
- None
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- not applicable
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Specific details on test material used for the study:
- None
- Species:
- rat
- Strain:
- other: Tif: RAIf (SPF) strain
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Healthy random bred rats of the Tif: RAIf (SPF) strain (7 to 8 weeks old) raised on the premises were used for these experiment. They were kept at a room temperature of 22±2 °C, at a relative humidity of 55±10 % and on a 10 hours light cycle day. They received ad libitum rat food - NAFAG, Gossau SG - and water. Prior to treatment the animals were adapted to our laboratories for a minimum of 4 days.
During the treatment and observation period the animals were housed in groups of 5 in Macrolon cages (type 3 ), individually marked with picric acid. - Route of administration:
- oral: gavage
- Vehicle:
- polyethylene glycol
- Remarks:
- polyethylene glycol (PAG 400), Fluka AG, Buchs SG, Art. 81170
- Details on oral exposure:
- FAT 31015/F was diluted to achieve the corresponding dosage level.
Volume (ml/kg body-weight): 10, 20 - Doses:
- 1000, 1500, 2000 and 3000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- Treatment and observations:
Animals fasted overnight were treated by single oral intubation. Physical condition and rate of deaths were monitored throughout the whole observation period.
Body weights:
Bodyweights were recorded immediately prior to dosing (control weights) and at 7 and 14 days.
Autopsies:
Surviving animals were submitted to a necropsy whenever they died, survivors at the end of the observation period. - Statistics:
- LD50 including 95 % confidence limits are calculated by the logit model.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 1 635 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 1 377 - <= 1 898
- Mortality:
- No mortality was observed in the rats treated at 1000 mg/kg bw. However, 1 male + 3 females and 4 males + 4 females were found dead at 1500 and 2000 mg/kg bw respectively. While, all the males and females treated at 3000 mg/kg bw were found dead.
- Clinical signs:
- other: The surviving animals recovered within 8 to 9 days. Sedation, dyspnoea, exophthalmos, ruffled fur, diarrhoea, curved body position and tremors were clinical signs observed at the tested dose levels.
- Gross pathology:
- No substance related gross organ changes were seen.
- Other findings:
- None
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The acute oral LD50 of FAT 31016/F in rats of both sexes observed over a period of 14 days was 1635 (1377-1898) mg/kg bw
- Executive summary:
The acute oral LD50 of FAT 31016/F was evaluated in a study conducted with the methodology similar to OECD Guideline 401. Groups of male and female rats (5 each) were administered with the test substance at doses of 1000, 1500, 2000 and 3000 mg/kg bw. No mortality was observed in the rats treated at 1000 mg/kg bw. However, 1 male + 3 females and 4 males + 4 females were found dead at 1500 and 2000 mg/kg bw, respectively. While, all the males and females treated at 3000 mg/kg bw were found dead. The surviving animals recovered within 8 to 9 days. Sedation, dyspnoea, exophthalmos, ruffled fur, diarrhoea, curved body position and tremors were clinical signs observed at the tested dose levels. Body weights were not affected by the administration of test substance at any of the doses. No substance related gross organ changes were seen. Hence, based on the findings of the study, the acute oral LD50 of FAT 31016/F in rats of both sexes observed over a period of 14 days was 1635 (1377-1898) mg/kg bw.
Reference
None
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 1 635 mg/kg bw
- Quality of whole database:
- Good quality study
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Data waiving:
- other justification
- Justification for data waiving:
- other:
Reference
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Data waiving:
- other justification
- Justification for data waiving:
- the study does not need to be conducted because the physicochemical and toxicological properties suggest no potential for a significant rate of absorption through the skin
Reference
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Acute oral toxicity
The acute oral LD50 of FAT 31016/F was evaluated in a study conducted with the methodology similar to OECD Guideline 401. Groups of male and female rats (5 each) were administered with the test substance at doses of 1000, 1500, 2000 and 3000 mg/kg bw. No mortality was observed in the rats treated at 1000 mg/kg bw. However, 1 male + 3 females and 4 males + 4 females were found dead at 1500 and 2000 mg/kg bw, respectively. While, all the males and females treated at 3000 mg/kg bw were found dead. The surviving animals recovered within 8 to 9 days. Sedation, dyspnoea, exophthalmos, ruffled fur, diarrhoea, curved body position and tremors were clinical signs observed at the tested dose levels. Body weights were not affected by the administration of test substance at any of the doses. No substance related gross organ changes were seen. Hence, based on the findings of the study, the acute oral LD50 of FAT 31016/F in rats of both sexes observed over a period of 14 days was 1635 (1377-1898) mg/kg bw.
Acute inhalation toxicity
Currently no study to assess the acute inhalation toxicity potential of Basic Red 046 Methylsulfate is available. However, the vapour pressure for Basic Red 046 Methylsulfate is expected to be low owing to the high boiling point (>175 °C),hence it is considered to have low volatility. The low partition coefficient of -1.86 again points to poor absorption across the respiratory tract. Basic Red 046 Methylsulfate was found to have high water solubility (734 g/L), hence the inhaled vapours may be retained within the mucus of the respiratory tract, thereby further limiting the absorption. The use of this substance will not result in aerosols, particles or droplets of an inhalable size, so exposure to humans via the inhalation route will be unlikely to occur. Further, Basic Red 046 Methylsulfate was evaluated for acute oral toxicity potential yielding a LD50 equal to 1635 mg/kg bw. Taking into consideration the low inhalation as well as low absorption potential if inhaled, it is expected to cause no more severe effects than already seen with acute oral toxicity study, with inhalation exposure. Hence, further experiments to assess acute inhalation toxicity were considered scientifically not necessary.
Acute dermal toxicity:
Currently no study to evaluate the acute dermal toxicity of Basic Red 046 Methylsulfate is available. The molecular weight of Basic Red 046 Methylsulfate is 432.5 g/mol, which indicates substance is too large for dermal absorption. The high water solubility (734 g/L) and low partition coefficient (log Pow = -1.86) of Basic Red 046 Methylsulfate, indicate the substance may be too hydrophilic to cross the lipid rich environment of the stratum corneum. Hence, the dermal uptake for the substance is expected to be low. Basic Red 046 Methylsulfate was evaluated for acute oral toxicity potential yielding a LD50equal to 2289 mg/kg bw, however no substance related systemic toxicity was reported. Further, the absence of systemic toxicity or mortality in skin irritation as well as sensitization studies, further supports the conclusion that no more severe effects than already seen with acute oral exposure, are expected via dermal route. Taking into consideration the above discussion, further experiments to assess acute dermal toxicity were considered scientifically not necessary.
Justification for classification or non-classification
Based on the available information, Basic Red 046 Methosulfate needs to be classified for acute oral toxicity as category 4 (H302), as per the Regulation EC No. 1272/2008 (CLP) criteria.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.